Literature DB >> 9820551

Molecular cloning and functional characterization of the rat analogue of human decay-accelerating factor (CD55).

S J Hinchliffe1, O B Spiller, N K Rushmere, B P Morgan.   

Abstract

We report here the cloning of cDNAs encoding two forms of the rat analogue of human decay-accelerating factor (DAF; CD55). Screening of a rat kidney cDNA library using a mouse DAF probe identified a partial cDNA encoding the 3' end of rat DAF. The 5' end of the cDNA was cloned using the rapid amplification of cDNA ends (RACE) technique. A second form of rat DAF was identified using 3'RACE. Cloning and sequencing of full length cDNAs for both forms showed that they were identical up to nucleotide 1143 except for a 51-bp insert in the ST-rich region of the second form. After nucleotide 1143, the two sequences diverged; the cDNA cloned from the library encoded a unique 112-amino acid "tail," whereas the second form, identified by 3'RACE, encoded an 18-amino acid hydrophobic stretch, which was predicted to be a glycosylphosphatidylinositol (GPI) anchor addition signal. Expression in the NIH-3T3 mouse fibroblast cell line confirmed that the short tail did encode a GPI-addition signal, whereas the longer tail caused the protein to be secreted. Northern blot analysis identified two distinct transcripts for the GPI form, as well as a variability in expression levels of the different transcripts in the panel of tissues screened. Southern blot analysis showed that both the GPI and secreted forms of rat DAF were expressed in a wide range of tissues. The GPI-linked form of rat DAF stably expressed in a murine fibroblast cell line reduced C3 deposition and conferred protection from lysis by rat serum.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9820551

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Production and functional analysis of rat CD59 and chimeric CD59-Crry as active soluble proteins in Pichia pastoris.

Authors:  R J Quigg; C He; B K Hack; J J Alexander; B P Morgan
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

2.  Decay accelerating factor in guinea-pig reproductive organs.

Authors:  C He; M Nonaka; T Tada; T Koji; W Li; N Okada; H Okada
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

3.  Tissue distribution of the rat analogue of decay-accelerating factor.

Authors:  O B Spiller; S M Hanna; B P Morgan
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

4.  Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities.

Authors:  C L Harris; O B Spiller; B P Morgan
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

5.  Molecular and functional analysis of mouse decay accelerating factor (CD55).

Authors:  C L Harris; N K Rushmere; B P Morgan
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

6.  Structure/function studies of human decay-accelerating factor.

Authors:  W G Brodbeck; L Kuttner-Kondo; C Mold; M E Medof
Journal:  Immunology       Date:  2000-09       Impact factor: 7.397

7.  Molecular cloning, expression and characterization of the rat analogue of human membrane cofactor protein (MCP/CD46).

Authors:  R Mead; S J Hinchliffe; B P Morgan
Journal:  Immunology       Date:  1999-09       Impact factor: 7.397

8.  Coupling complement regulators to immunoglobulin domains generates effective anti-complement reagents with extended half-life in vivo.

Authors:  C L Harris; A S Williams; S M Linton; B P Morgan
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

9.  Expression of Membrane Complement Regulatory Proteins Crry and CD55 in Normal Rats.

Authors:  Chie Kato; Atsuhiko Kato; Kenji Adachi; Etsuko Fujii; Kaori Isobe; Takeshi Watanabe; Tsuneo Ito; Masami Suzuki
Journal:  J Toxicol Pathol       Date:  2013-07-10       Impact factor: 1.628

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.